Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators

Overview

Journal Life (Basel)

Specialty Biology

Date 2021 Oct 23

PMID 34685444

Citations 11

Authors

Claudia Homorogan

Diana Nitusca

Edward Seclaman

Virgil Enatescu

Catalin Marian

Affiliations

Soon will be listed here.

Abstract

Major depressive disorder (MDD) is a recurrent debilitating illness that represents a major health burden due to its increasing worldwide prevalence, unclear pathological mechanism, nonresponsive treatment, and lack of reliable and specific diagnostic biomarkers. Recently, microRNA species (miRs) have gained particular interest because they have the ability to post-transcriptionally regulate gene expression by modulating mRNA stability and translation in a cohesive fashion. By regulating entire genetic circuitries, miRs have been shown to have dysregulated expression levels in blood samples from MDD patients, when compared to healthy subjects. In addition, antidepressant treatment (AD) also appears to alter the expression pattern of several miRs. Therefore, we critically and systematically reviewed herein the studies assessing the potential biomarker role of several candidate miRs for MDD, as well as treatment response monitoring indicators, in order to enrich the current knowledge and facilitate possible diagnostic biomarker development for MDD, which could aid in reducing both patients' burden and open novel avenues toward a better understanding of MDD neurobiology.

Citing Articles

in Major Depression: Possible Association of and with Childhood Traumas.

Mert A, Yucens B, Karagur E, Akca H, Tumkaya S, Atesci F Clin Psychopharmacol Neurosci. 2025; 23(1):133-143.

PMID: 39820119 PMC: 11747731. DOI: 10.9758/cpn.24.1218.

Identification of Specific Plasma miRNAs as Potential Biomarkers for Major Depressive Disorder.

Prodan-Barbulescu C, Alin C, Faur I, Bujor G, Seclaman E, Enatescu V Biomedicines. 2024; 12(10).

PMID: 39457478 PMC: 11505153. DOI: 10.3390/biomedicines12102165.

Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective.

Prodan-Barbulescu C, Ghenciu L, Seclaman E, Bujor G, Enatescu V, Danila A Curr Issues Mol Biol. 2024; 46(10):10846-10853.

PMID: 39451524 PMC: 11506240. DOI: 10.3390/cimb46100644.

Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review.

Wang Y, Huang Y, Luo X, Lai X, Yu L, Zhao Z Heliyon. 2024; 10(19):e39026.

PMID: 39435111 PMC: 11492588. DOI: 10.1016/j.heliyon.2024.e39026.

The Contribution of Genetic Testing in Optimizing Therapy for Patients with Recurrent Depressive Disorder.

Platona R, Voita-Mekeres F, Tudoran C, Tudoran M, Enatescu V Clin Pract. 2024; 14(3):703-717.

PMID: 38804388 PMC: 11130888. DOI: 10.3390/clinpract14030056.

References

Hajszan T, MacLusky N, Leranth C . Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci. 2005; 21(5):1299-303. DOI: 10.1111/j.1460-9568.2005.03968.x. View

Andreasen N . Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science. 1997; 275(5306):1586-93. DOI: 10.1126/science.275.5306.1586. View

Goh S, Chao Y, Dheen S, Tan E, Tay S . Role of MicroRNAs in Parkinson's Disease. Int J Mol Sci. 2019; 20(22). PMC: 6888719. DOI: 10.3390/ijms20225649. View

Lu T, Rothenberg M . MicroRNA. J Allergy Clin Immunol. 2017; 141(4):1202-1207. PMC: 5889965. DOI: 10.1016/j.jaci.2017.08.034. View

Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Treziny C, Verrier L . Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry. 2012; 2:e185. PMC: 3565773. DOI: 10.1038/tp.2012.112. View

Fang Y, Qiu Q, Zhang S, Sun L, Li G, Xiao S . Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression. J Affect Disord. 2018; 227:745-751. DOI: 10.1016/j.jad.2017.11.090. View

Honer W . Assessing the machinery of mind: synapses in neuropsychiatric disorders. J Psychiatry Neurosci. 1999; 24(2):116-21. PMC: 1188991. View

Wang X, Sundquist K, Hedelius A, Palmer K, Memon A, Sundquist J . Circulating microRNA-144-5p is associated with depressive disorders. Clin Epigenetics. 2015; 7:69. PMC: 4509564. DOI: 10.1186/s13148-015-0099-8. View

Kuang W, Dong Z, Tian L, Li J . MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment. Braz J Med Biol Res. 2018; 51(7):e7212. PMC: 5972018. DOI: 10.1590/1414-431x20187212. View

10.

Gheysarzadeh A, Sadeghifard N, Afraidooni L, Pooyan F, Mofid M, Valadbeigi H . Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202. J Res Med Sci. 2018; 23:69. PMC: 6116664. DOI: 10.4103/jrms.JRMS_879_17. View

11.

Friedrich M . Depression Is the Leading Cause of Disability Around the World. JAMA. 2017; 317(15):1517. DOI: 10.1001/jama.2017.3826. View

12.

Wang S, Mu R, Li C, Dong S, Geng D, Liu Q . microRNA-124 targets glucocorticoid receptor and is involved in depression-like behaviors. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 79(Pt B):417-425. DOI: 10.1016/j.pnpbp.2017.07.024. View

13.

Rajkowska G, Miguel-Hidalgo J . Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007; 6(3):219-33. PMC: 2918806. DOI: 10.2174/187152707780619326. View

14.

Li Y, Xu M, Gao Z, Wang Y, Yue Z, Zhang Y . Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS One. 2013; 8(5):e63648. PMC: 3660391. DOI: 10.1371/journal.pone.0063648. View

15.

Malphettes L, Fussenegger M . Impact of RNA interference on gene networks. Metab Eng. 2006; 8(6):672-83. DOI: 10.1016/j.ymben.2006.07.005. View

16.

Launay J, Mouillet-Richard S, Baudry A, Pietri M, Kellermann O . Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl Psychiatry. 2012; 1:e56. PMC: 3309472. DOI: 10.1038/tp.2011.54. View

17.

McEwen B . Effects of adverse experiences for brain structure and function. Biol Psychiatry. 2000; 48(8):721-31. DOI: 10.1016/s0006-3223(00)00964-1. View

18.

Griffiths S, Scott H, Glover C, Bienemann A, Ghorbel M, Uney J . Expression of long-term depression underlies visual recognition memory. Neuron. 2008; 58(2):186-94. DOI: 10.1016/j.neuron.2008.02.022. View

19.

Wang M, Qin L, Tang B . MicroRNAs in Alzheimer's Disease. Front Genet. 2019; 10:153. PMC: 6405631. DOI: 10.3389/fgene.2019.00153. View

20.

Sala M, Perez J, Soloff P, Ucelli di Nemi S, Caverzasi E, Soares J . Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol. 2004; 14(5):393-405. DOI: 10.1016/j.euroneuro.2003.12.005. View